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ARTICLE
Mutations in FAM20C Are Associated with Lethal Osteosclerotic
Bone Dysplasia (Raine Syndrome), Highlighting a Crucial
Molecule in Bone Development
M. A. Simpson, R. Hsu, L. S. Keir, J. Hao, G. Sivapalan, L. M. Ernst, E. H. Zackai, L. I. Al-Gazali,
G. Hulskamp, H. M. Kingston, T. E. Prescott, A. Ion, M. A. Patton, V. Murday, A. George,
and A. H. Crosby
The generation and homeostasis of bone tissue throughout development and maturity is controlled by the carefully
balanced processes of bone formation and resorption. Disruption of this balance can give rise to a broad range of skeletal
pathologies. Lethal osteosclerotic bone dysplasia (or, Raine syndrome) is an autosomal recessive disorder characterized
by generalized osteosclerosis with periosteal bone formation and a distinctive facial phenotype. Affected individuals
survive only days or weeks. We have identified and defined a chromosome 7 uniparental isodisomy and a 7p telomeric
microdeletion in an affected subject. The extent of the deleted region at the 7p telomere was established by genotyping
microsatellite markers across the telomeric region. The region is delimited by marker D7S2563 and contains five tran-
scriptional units. Sequence analysis of FAM20C, located within the deleted region, in six additional affected subjects
revealed four homozygous mutations and two compound heterozygotes. The identified mutations include four nonsy-
nonymous base changes, all affecting evolutionarily conserved residues, and four splice-site changes that are predicted
to have a detrimental effect on splicing. FAM20C is a member of the FAM20 family of secreted proteins, and its mouse
orthologue (DMP4) has demonstrated calcium-binding properties; we also show by in situ hybridization its expression
profile in mineralizing tissues during development. This study defines the causative role of FAM20C in this lethal os-
teosclerotic disorder and its crucial role in normal bone development.
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The sclerosing bone dysplasias are an extended hetero-
geneous group of predominantly inherited conditionschar-
acterized by abnormal hardening and increase in density
of bone.1 The neonatal osteosclerotic dysplasias, which
include lethal osteosclerotic bone dysplasia, are set apart
because of their aggressive nature and early onset.1 The
first reported case of lethal osteosclerotic bone dysplasia,
also commonly referred to as “Raine syndrome” (MIM
259775), was presented in 1989, a female neonate, born
at term, who died at age 86 min.2 Since this original report,
an additional 13 cases have been described.3–11 Affected
individuals survive only days or weeks, with the cause of
death most commonly reported as respiratory failure,
which may be due to thoracic malformation. Radiographic
studies have shown generalized increase in the density of
all bones and marked increase in the ossification of the
skull.12 The increased ossification of the basal structures
of the skull and the facial bones underlies the character-
istic facial features, which include narrow prominent fore-
head, proptosis of the eyes, depressed nasal bridge, and mid-
facial hypoplasia. Periosteal bone formation is also char-
acteristic of this disorder and differentiates it from osteo-
petrosis and other known lethal and nonlethal osteos-
clerotic bone dysplasias.9 The periosteal bone formation
typically extends along the diaphysis of long bones, ad-
jacent to areas of cellular soft tissue.11
Raine syndrome appears to be inherited in an autosomal
recessive fashion, since many of the reported case patients
are the offspring of consanguineous unions, and recur-
rence in siblings has also been reported.9,11 In the current
study, we identified an unusual chromosome 7 rearrange-
ment and microdeletion in an affected subject and subse-
quently identified mutations in the FAM20C gene (MIM
*611061), located within the deleted region, in six addi-
tional affected subjects.
Material and Methods
Sample Ascertainment
We studied seven unrelated affected individuals and samples from
the parents of three of the affected individuals. Three subjects
were the offspring of consanguineous unions. All subjects pre-
sented at birth with features consistent with the diagnosis of
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Raine syndrome and died within the first few weeks of life. Sam-
ples for blood and/or skin biopsy were obtained after appropriate
informed consent was given by the parents.
Cytogenetic Analysis
Chromosomal analysis was performed on 24–48 h–synchronized
cell cultures. Karyotyping was performed using standard trypsin-
Giemsa staining. FISH was performed according to standard pro-
tocols. The RP11-90P13 chromosome 7 telomeric probe and a
chromosome 7 centromeric probe were directly labeled with fluo-
rochromes. Probes were denatured at 80C for 5 min and were
preannealed for 2 h at 37C with a 50-fold excess of both Cot-1
DNA (Life Technologies) and DNA from human placenta (Sigma).
Genotyping and Sequence Analysis
Genotypes of microsatellite markers were determined by PCR am-
plification and subsequent analysis by PAGE and were visualized
by silver staining. Intronic, exon-flanking primers were designed
to amplify all 10 exons and associated splice junctions of FAM20C.
PCR-amplified fragments were purified using QIAquick PCR clean-
up columns (QIAGEN) and were sequenced using the BigDye ter-
minator chemistry (v. 3.5) (Applied Biosystems) on an ABI3100
genetic analyzer (Applied Biosystems). Sequences were aligned and
compared with reference sequences with use of SeqScape software
(v. 2.0) (Applied Biosystems).
Bioinformatic Analysis
Cross-species sequence alignments were performed using the
ClustalW program.13 Analysis of splice-site variants was per-
formed using the Automated Splice Site–Analysis Server.14
In Situ Hybridization
The full-length mouse FAM20C (DMP4) cDNA was linearized for
in vitro transcription with use of appropriate enzymes. The anti-
sense and sense samples complementary to target mRNA were
prepared by in vitro transcription with use of T3 or T7 polymerase
(Promega) with 35S-labeled dUTP (ICN). Briefly, tissues from em-
bryonic day 15 (E15) and postnatal day 1 (P1) mice were fixed
overnight with 4% paraformaldehyde in PBS (pH 7.4) at 4C, were
washed overnight with PBS at 4C, and were dehydrated and
embedded in paraffin. Sections (5 mm) were cut, were mounted
on charged glass slides, were dewaxed in xylene, and were re-
hydrated. After the sections were washed in PBS, they were di-
gested with 200 mU/ml proteinase K, were postfixed, and were
acetylated with 0.25% acetic anhydride. The sections were hy-
bridized overnight at 55C with radiation-labeled riboprobes. The
sections were then washed with 50% formamide, 2# SSC (0.3 M
NaCl containing 0.03 M sodium citrate) for 30 min at 55C, were
digested with RNase A, and were washed once with 2# SSC and
twice with 0.2# SSC for 20 min at 55C. The signal was visualized
with NBT2 silver; then, the slides were counterstained with he-
matoxylin and were dehydrated and mounted.
RNA Isolation, RT-PCR, and Northern-Blot Analysis
Total RNA from adult mouse tissues was isolated. For RT-PCR, 3
mg of total RNA was reverse transcribed for 90 min at 42C with
Superscript II (GIBCO/BRL). PCR Supermix (GIBCO/BRL) was used
in the PCR. For northern blotting, 10 mg total RNA was fraction-
ated by electrophoresis through 0.8% agarose gels containing for-
maldehyde and were blotted onto Hybond nylon membrane (Am-
ersham Biosciences). Full-length mouse FAM20C (DMP4) cDNA
was labeled with [-P]dCTP with use of a random labeling system
(Ambion). Hybridization was performed in ExpressHyb hybridi-
zation buffer (Clontech) at 68C. Membranes were washed twice
with 2# SSC, 0.1% SDS, at 42C for 20 min and twice in 0.1#
SSC, 0.1% SDS, at 56C for 30 min, and were exposed overnight
to x-ray film at 80C.
Results
Cytogenetic examination by Giemsa staining of a sample
from a previously unreported male child with lethal osteo-
sclerotic bone dysplasia, who died 2 h after birth, revealed
the presence of a pseudodicentric chromosome 7 (fig. 1a)
with the karyotype 45, XY psudic (7;7) (p22;p22). Analysis
of parental chromosomes revealed normal karyotypes. Hy-
bridization with a chromosome 7p telomeric FISH probe
(RP11-90P13) confirmed the deletion of the terminal por-
tions of 7p at the fusion point of the pseudodicentric chro-
mosome (fig. 1b). Genotyping of microsatellite markers
located across chromosome 7 revealed uniparental isodi-
somy, with paternal origin of the two copies of chromo-
some 7 present within the pseudodicentric chromosome
(data not shown).
The child was born at 37 wk of gestation; at birth, the
child breathed independently but developed respiratory
distress. Despite medical intervention to improve respira-
tion, the patient died 3 h after delivery. Postmortem ex-
amination revealed the presence of multiple congenital
abnormalities consistent with a Raine syndrome diagno-
sis: prominent forehead, short neck, proptosis, midfacial
hypoplasia, and a depressed nasal bridge (table 1, subject
1). Radiological investigation revealed diffuse osteoscle-
rosis, with irregular periosteal bone formation along the
clavicles and ribs. The skull had wide cranial sutures with
evidence of premature closure, whereas the base of the
skull showed an increased thickness of all bony landmarks.
The extent of the deleted region of the 7p telomere was
established by genotyping microsatellite markers across
the telomeric region. Markers D7S2477 and D7S1484 are
contained within the deleted region and therefore were
absent in the affected subject. The next-most-distalmarker
on chromosome 7p, D7S2563, positioned proximal to
D7S1484, was successfully amplified from the DNA of the
affected subject and displayed a genotype consistent with
uniparental isodisomy (data not shown). The region distal
to D7S2563 was therefore considered a candidate for the
region containing the causative gene in this disorder. A
continuous human sequence across this region was only
recently completed with the alternative assembly NT_
079592 (GenBank) (fig. 1c). The region contains just
five known or predicted genes: FLJ45445, which has
an unclassified transcription discrepancy; LOC730345,
LOC730346, and LOC651986, which are derived by au-
tomated computational analysis; and FAM20C, a 10-exon
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Figure 1. a, G banding of the pseudodicentric chromosome 7. b, FISH staining with probes directed against chromosome 7 centromere
(pink) and chromosome 7p telomere (blue). The upper panel displays a normal karyotype from the affected child’s father, and the lower
panel is from the affected child, with an absence of signal from the chromosome 7pter probe. c, Schematic representation, from contig
NT_079592 (GenBank), of the terminal region of chromosome 7p, including the location of the deleted 7pter FISH probe. Marker D7S2563
delimits the deleted region, which contains five potential transcriptional units.
gene that represents the most telomeric confirmed gene
model on chromosome 7p.
The previous study of FAM20C,15 as well as our recent
studies of its mouse orthologue (DMP4),16 identified this
gene as an excellent candidate in the pathogenesis of this
disorder. The coding regions and associated splice sites of
this gene were therefore sequenced in a cohort of six af-
fected subjects (three presented elsewhere in clinical case
reports3,10,11 and three previously unreported additional
subjects affected with lethal osteosclerotic bone dysplasia)
and three sets of parents. (An overview of clinical features
is presented in table 1.) Sequence variations consistent
with autosomal recessive inheritance were identified in all
six subjects (fig. 2). Homozygous changes were identified
in four subjects, three of whom were the offspring of con-
sanguineous unions, and comprised three nonsynonymous
base changes (1093GrA [Gly365Arg[, 1121TrG [Leu374-
Arg], and 1603CrT [Arg535Trp]) and an intron 4/exon 5
acceptor splice-site change (c915-3CrG). Two compound
heterozygotes were also identified in affected subjects with
no evidence of parental consanguinity—one heterozygous
for a nonsynonymous base change (1094GrA [Gly365-
Glu]) and an intron 7/exon 8 acceptor splice-site change
(c1322-2ArG) and the second with heterozygous variants
in the exon 4/intron 4 donor splice site (c9145GrC) and
an intron 8/exon 9 acceptor splice site (c1404-1GrA). In
the three cases where parental DNA was available, the
parents were found to be heterozygous for the respective
variants (data not shown). The eight variants identified
were not present in at least 300 control chromosomes.
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Table 1. Clinical Features and Mutations Identified for Subjects with Raine Syndrome
Subject
Chromosomal Abnormality
or Mutation(s) in FAM20C Sex Consanguinity
Gestation
(wk)
Survived
110 d Osteosclerosis PBFa
Cerebral
Calcifications
Thoracic
Hypoplasia
Pulmonary
Hypoplasia Case Report
1 45,XY psudic (7;7) (p22;p22) M  37    U  
2 1603CrT (Arg535Trp) M  37    U   Kingston et al.3
3 1093GrA (Gly365Arg) M  38    U  
4 c915-3CrG M  36       Al-Gazali et al.10
5 1121TrG (Leu374Arg) F  32       Hulskamp et al.11
6 1094GrA (Gly365Glu) and
c1322-2ArG F  38      
7 c9145GrC and c1404-1GrA F  32      
NOTE.—All subjects had prominent forehead, proptosis, midfacial hypoplasia, and depressed nasal bridge. A plus sign () p present; a minus sign () p absent; U
p unknown status.
a PBF p periosteal bone formation.
FAM20C orthologues are found in a range of species.
Cross-species alignment of their protein sequences reveals
a high level of evolutionary conservation. Human and
mouse (DMP4) sequences display 85% identity and 91%
similarity, and similarly high levels are seen across other
species (fig. 2). The N-terminal region contains a signal
peptide sequence that shows moderate conservation across
all species analyzed. However, it is the C-terminal half of
the protein that displays the highest level of conservation.
This region has been termed the “conserved C-terminal
domain” (CCD), and its sequence structure overlaps the
DUF1193 domain.15 The 3-aa residues altered by the four
nonsynonymous base changes identified in affected sub-
jects are all evolutionarily conserved residues within the
CCD.
Individual information analysis of the four identified
splice-site variants suggests that each mutation has a weak-
ening effect on splice-site binding. (See fig. 2 for calculated
Ri and Z scores.) Three of the variants (c9145GrC, c915-
3CrG, and c1322-2ArG) greatly weaken the splice site
predicted by the Automated Splice Site–Analysis Server,14
and the fourth (c1404-1GrA) is predicted to completely
abolish splicing at this junction. The donor-site mutation
(c9145GrC) in the exon 4/intron 4 splice junction re-
duces the Ri score from 10.7 to 6.8 bits, which typically
would lead to the prediction of a leaky mutation. How-
ever, this splice site is located within a common polymor-
phic 34-bp repeat (911_c91430dup) consisting of the last
4 bases of exon 4 and the first 30 bases of intron 4. The
c9145GrC mutation is located on a chromosome with
a 68-bp allele containing two copies of the repeat; there-
fore, a pre-existing 10.7-bit cryptic splice site exists 34
bases downstream from the mutated junction, which is
therefore likely to be preferentially employed for splicing.
The identification of mutations in FAM20C in affected
patients highlights a crucial role of this molecule in the
development of mineralized tissue. The expression pattern
of the mouse FAM20C orthologue (DMP4) during devel-
opment was investigated by situ hybridization in sagittal
sections of E15 (whole body) and P1 (head) mice. Notably,
strong expression was observed within chondroblasts of
the developing somites and limb girdle in the E15 mouse
(fig. 3a). Sections of alveolar bone in P1 mice revealed
expression in osteoblasts and ameloblasts and particularly
strong expression in odontoblasts at this early stage of
predentine mineralization (fig. 3b). RT-PCR amplification
and the detection of a single transcript of ∼3 kb by north-
ern-blot analysis verified the presence of FAM20C (DMP4)
in both long bone and tooth germ (fig. 3c).
Discussion
The recessive expression of the mutations identified and
the fact that they are predicted either to alter evolution-
arily conserved amino acids or to have a strong detri-
mental effect on splicing, taken together with the telo-
meric deletion containing the FAM20C gene, strongly sug-
gest that loss of function of this protein is responsible for
the disease phenotype. Despite the spectrum of mutations
identified in FAM20C in the six subjects and a telomeric
deletion of the region containing the gene in another,
correlation between genotype and phenotype is hindered
by the complexity and severity of Raine syndrome pre-
sentations. Whereas there is some variation in presenta-
tion and length of survival, correlation to genotype is
complicated by the small number of cases, limited clinical
information, and different therapeutic interventions. How-
ever, it does not appear that there is any clear correlation
between the severity of presentation and the type of mu-
tation (i.e., splice site or missense), and the compound
heterozygous subjects are as profoundly affected as are the
homozygous subjects. Interestingly, the deleted region in
patient 1, delimited by marker D7S2563, contains four
additional putative genes. However, the phenotype in this
case is characteristic of Raine syndrome, and none of the
features of this subject appear to be unique and all have
been reported in previous cases, although the severity of
the phenotype could easily mask any additional effects of
the deletion of these genes.
FAM20C was reported as a member of the evolutionarily
conserved FAM20 family of secreted proteins that show
sequence similarity to FAM20A (MIM *611062), which was
identified through its differential expression during hema-
topoietic differentiation.15 We have recently shown that
overexpression of the mouse homologue of this gene ac-
celerates the odontoblast differentiation process and min-
eralized nodule formation and that in vitro silencing by
RNA interference inhibits odontoblast differentiation and
Figure 2. Sequence chromatograms, predicted effects, and locations of the mutations identified in the six additional affected indi-
viduals. Mutations are present in affected individuals as homozygotes, apart from two compound heterozygotes (c9145GrC, c1401-
1GrA, designated by a number sign [#], and 1094GrA, c1322-2ArG, designated by an asterisk [*]). Statistical analysis of each of
the splice-site variants is displayed above the chromatograms (blue path). Also shown is a schematic representation of multiple-species
sequence alignment of the FAM20C protein sequences affected by respective variants (red path).
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Figure 3. a, In situ hybridization of the mouse FAM20C orthologue (DMP4) on E15 mouse, with light microscopy and dark field images
showing the developing vertebral column with expression on the mineralizing surface of somites (red arrow) and limb girdle (blue
arrow). b, Light microscopy and dark field images showing expression of FAM20C (DMP4) in osteoblasts (yellow arrow), odontoblasts
(red arrow), and ameloblasts (blue arrow) of the alveolar bone in a P1 mouse. c, PCR analysis of Fam20C (DMP4) mRNA from multiple
tissues from a P5 SD rat (1 p spleen, 2 p skeletal muscle, 3 p bone, and 4 p tooth germ) (left). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) is used as an internal control. Right, With northern-blot analysis, 20 mg of total RNA isolated from P5 rats (1
p spleen, 2 p skeletal muscles, 3 p bones, and 4 p tooth germs), was electrophoresed, blotted, and probed for FAM20C (DMP4).
The blot was stripped and reprobed for GAPDH.
mineralization.16 We also showed that this molecule binds
calcium and that a conformational change in the protein
is associated with this interaction.16 Interestingly, reduced
serum calcium levels have been reported in lethal osteos-
clerotic bone dysplasia, although urinary excretion of cal-
cium and phosphate has been within the normal range
for the same subjects.11 The formation of calcified tissue
is a well-regulated process, with a complex interplay be-
tween both promoters and inhibitors of mineralization.
Although more-detailed further investigations are re-
quired, the apparent contradiction between the proposed
loss-of-function mutations reported in this study and the
mineralization-promoting properties of FAM20C in vitro
may reflect the conformational change of FAM20C in the
presence of excess calcium.16 The identification of FAM20C
as the gene responsible for the increase in bone density
and appositional bone formation that underlies this lethal
human disease defines a critical component in the grow-
ing list of molecules known to be involved in bone de-
velopment and mineralization.
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